Paper75439
Maintenance treatment of recurrent peptic ulcer by cimetidine.
Bodemar G and 1 other. Lancet, 1978. Cited by 216 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Maintenance treatment of recurrent peptic ulcer by cimetidine. Papers, record 75439. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/75439
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cimetidine | Major topic |
| Guanidines | Major topic |
| Peptic Ulcer | Major topic |
| Adult | |
| Aged | |
| Chronic Disease | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Placebos | |
| Recurrence | |
| Time Factors |
Source PubMed
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 216 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24,643,207 | Cimetidine synergizes with Praziquantel to enhance the immune response of HBV DNA vaccine via activating cytotoxic CD8(+) T cell. | Hum Vaccin Immunother | 2014 | https://conductscience.org/library/papers/24643207 | PubMed |
| 16,184,420 | Antiulcer drugs and gastric cancer. | Dig Dis Sci | 2005 | https://conductscience.org/library/papers/16184420 | PubMed |
| 11,219,486 | Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists. | Drug Saf | 2001 | https://conductscience.org/library/papers/11219486 | PubMed |
| 10,360,308 | Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis. | Trans Am Ophthalmol Soc | 1998 | https://conductscience.org/library/papers/10360308 | PubMed |
| 8,174,950 | Acid, motility, and ulcers: a comparison of cisapride with placebo in the prevention of duodenal ulcer relapse. | Gut | 1993 | https://conductscience.org/library/papers/8174950 | PubMed |
| 7,410,042 | Cimetidine and duodenal ulcer: a study of initial and low dosage maintenance treatment in Ireland. | Ir J Med Sci | 1980 | https://conductscience.org/library/papers/7410042 | PubMed |
| 7,249,489 | Pharmacokinetics of cimetidine after single doses and during continuous treatment. | Clin Pharmacokinet | 1981 | https://conductscience.org/library/papers/7249489 | PubMed |
| 7,220,403 | Effect of treatment with cimetidine for one year on gastrin cell and parietal cell function and sensitivity to cimetidine in patients with duodenal or gastric ulcers. | Postgrad Med J | 1980 | https://conductscience.org/library/papers/7220403 | PubMed |
| 7,205,728 | Problems in the medical treatment of peptic ulcers. | J R Coll Physicians Lond | 1980 | https://conductscience.org/library/papers/7205728 | PubMed |
| 7,104,165 | Clinical assessment of antisecretory drugs in man. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7104165 | PubMed |
| 7,065,745 | Cimetidine versus surgery for recurrent ulcer after gastric surgery. | Ann Surg | 1982 | https://conductscience.org/library/papers/7065745 | PubMed |
| 7,042,252 | Cimetidine or propantheline combined with antacid therapy for short-term treatment of duodenal ulcer. | Dig Dis Sci | 1982 | https://conductscience.org/library/papers/7042252 | PubMed |
| 7,000,474 | Cimetidine vs placebo in duodenal ulcer therapy. Six-week controlled double-blind investigation without any antacid therapy. | Dig Dis Sci | 1980 | https://conductscience.org/library/papers/7000474 | PubMed |
| 6,994,084 | Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study. | Postgrad Med J | 1980 | https://conductscience.org/library/papers/6994084 | PubMed |
| 6,986,242 | Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study. | Dig Dis Sci | 1980 | https://conductscience.org/library/papers/6986242 | PubMed |
| 6,880,227 | Surgery or cimetidine? II. Comparison of two plans of treatment: operation or cimetidine given as a low maintenance dose. | World J Surg | 1983 | https://conductscience.org/library/papers/6880227 | PubMed |
| 6,786,895 | Effect of fifteen months of double-blind treatment with cimetidine and placebo on peptic ulcer recurrence. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6786895 | PubMed |
| 6,489,091 | Monthly fluctuations of active duodenal ulcers. | Dig Dis Sci | 1984 | https://conductscience.org/library/papers/6489091 | PubMed |
| 6,315,333 | Drugs for the prevention of peptic ulcer recurrence. | Drugs | 1983 | https://conductscience.org/library/papers/6315333 | PubMed |
| 6,301,956 | Ranitidine in the prevention of gastric and duodenal ulcer relapse. | Gut | 1983 | https://conductscience.org/library/papers/6301956 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HRH2 | 3,274 | PubTator's text mining | https://conductscience.org/library/genes/3274 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/75439
GET https://conductscience.org/api/papers/v1/75439/cited_by?page=2